Originalsprog | Engelsk |
---|---|
Tidsskrift | Blood |
Vol/bind | 120 |
ISSN | 0006-4971 |
Status | Udgivet - 1 nov. 2012 |
Udgivet eksternt | Ja |
First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma PatientsTreated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy
Francesco Annibale D'Amore, S Leppä, M Gomes da Silva, T Relander, Peter De Nully Brown, E Weidmann, GF Lauritzsen, A Pezzutto, A Van Hoof, M Van Gelder, J Doorduijn, KL Wu, JC Kluin-Nelemans, PJ Lugtenburg, M Jankovska, M Merup, U-M Fagerli, J Walewski, H Hagberg, JM Mariz
Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review